← Eichor
Condition: Irritable Bowel Syndrome With Diarrhea Ibs D Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Irritable Bowel Syndrome With Diarrhea Ibs D

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
Phase 3 · 10 location(s) · Biocodex · NCT07168434Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
NA · 12 location(s) · Devintec Sagl · NCT06681012The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Related Gast
NA · 1 location(s) · Nimble Science Ltd. · NCT06317441A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome
Phase 2 · 110 location(s) · GlaxoSmithKline · NCT07519395Effects of the Multispecies Probiotic Ecologic Barrier in IBS Patients With Upper GI Symptoms and Anxiety, Depression, o
NA · 1 location(s) · Institute of Gastroenterology and Hepatology, Vietnam · NCT07656623A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Phase 2 · 89 location(s) · Eli Lilly and Company · NCT07545759Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomi
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07581756Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Phase 2 · 46 location(s) · AbbVie · NCT03339128Efficacy of Rifaximin With NAC in IBS-D
Phase 2 · 1 location(s) · Mark Pimentel, MD · NCT06727422Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium,
Phase 1 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06960369A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D
Phase 3 · 2 location(s) · Guangzhou Zhiyi Biotechnology Co., Ltd. · NCT06247046
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.